Regulus Therapeutics Inc. (RGLS) Operating Lease, Liability USD 2018 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease.
Summary
Regulus Therapeutics Inc. quarterly Operating Lease, Liability history and growth rate from 2018 to 2024.
  • Regulus Therapeutics Inc. Operating Lease, Liability for the quarter ending March 31, 2024 was $1.6 M, a 29.4% decline year-over-year.
Operating Lease, Liability, Quarterly (USD)
Operating Lease, Liability, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $1.6 M -$664 K -29.4% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $1.77 M -$649 K -26.9% Dec 31, 2023 10-K 2024-03-21
Q3 2023 $1.94 M -$634 K -24.7% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $2.1 M -$618 K -22.7% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $2.26 M -$604 K -21.1% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $2.42 M -$589 K -19.6% Dec 31, 2022 10-K 2024-03-21
Q3 2022 $2.57 M -$575 K -18.3% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $2.72 M -$533 K -16.4% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $2.87 M -$357 K -11.1% Mar 31, 2022 10-Q 2022-05-13
Q4 2021 $3.01 M +$2.59 M +621% Dec 31, 2021 10-K 2023-03-23
Q3 2021 $3.15 M +$2.63 M +513% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 $3.25 M +$2.65 M +438% Jun 30, 2021 10-Q 2021-08-10
Q1 2021 $3.22 M +$2.53 M +365% Mar 31, 2021 10-Q 2021-05-14
Q4 2020 $417 K -$361 K -46.4% Dec 31, 2020 10-K 2021-03-09
Q3 2020 $513 K -$348 K -40.4% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $605 K +$605 K Jun 30, 2020 10-Q 2020-08-13
Q1 2020 $693 K +$693 K Mar 31, 2020 10-Q 2020-05-14
Q4 2019 $778 K -$10.5 M -93.1% Dec 31, 2019 10-K 2020-03-12
Q3 2019 $861 K Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $0 Jun 30, 2019 10-Q 2020-11-05
Q1 2019 $0 Mar 31, 2019 10-Q 2020-08-13
Q4 2018 $11.3 M Jan 1, 2019 10-Q 2019-11-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.